161 related articles for article (PubMed ID: 8695802)
21. Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
Komissarov AA; Florova G; Azghani A; Karandashova S; Kurdowska AK; Idell S
Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L682-92. PubMed ID: 23997178
[TBL] [Abstract][Full Text] [Related]
22. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.
Wilhelm S; Wilhelm O; Schmitt M; Graeff H
Biol Chem Hoppe Seyler; 1994 Sep; 375(9):603-8. PubMed ID: 7840902
[TBL] [Abstract][Full Text] [Related]
24. Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor.
al-Roof Higazi A; Aceto JF; Kniss D; Upson R; Cohen R; Dichek DA; Cines DB
Biochemistry; 1996 May; 35(21):6884-90. PubMed ID: 8639640
[TBL] [Abstract][Full Text] [Related]
25. Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor.
Conese M; Olson D; Blasi F
J Biol Chem; 1994 Jul; 269(27):17886-92. PubMed ID: 8027043
[TBL] [Abstract][Full Text] [Related]
26. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction.
Høyer-Hansen G; Behrendt N; Ploug M; Danø K; Preissner KT
FEBS Lett; 1997 Dec; 420(1):79-85. PubMed ID: 9450554
[TBL] [Abstract][Full Text] [Related]
27. A region in domain II of the urokinase receptor required for urokinase binding.
Bdeir K; Kuo A; Mazar A; Sachais BS; Xiao W; Gawlak S; Harris S; Higazi AA; Cines DB
J Biol Chem; 2000 Sep; 275(37):28532-8. PubMed ID: 10864923
[TBL] [Abstract][Full Text] [Related]
28. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
29. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F
J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
Ellis V
J Biol Chem; 1996 Jun; 271(25):14779-84. PubMed ID: 8662951
[TBL] [Abstract][Full Text] [Related]
31. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
Gårdsvoll H; Werner F; Søndergaard L; Danø K; Ploug M
Protein Expr Purif; 2004 Apr; 34(2):284-95. PubMed ID: 15003263
[TBL] [Abstract][Full Text] [Related]
32. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase.
Kounnas MZ; Henkin J; Argraves WS; Strickland DK
J Biol Chem; 1993 Oct; 268(29):21862-7. PubMed ID: 7691818
[TBL] [Abstract][Full Text] [Related]
33. The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer.
Mazar AP
Anticancer Drugs; 2001 Jun; 12(5):387-400. PubMed ID: 11395568
[TBL] [Abstract][Full Text] [Related]
34. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
35. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.
Murciano JC; Higazi AA; Cines DB; Muzykantov VR
J Control Release; 2009 Nov; 139(3):190-6. PubMed ID: 19616049
[TBL] [Abstract][Full Text] [Related]
36. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.
Jo M; Thomas KS; Wu L; Gonias SL
J Biol Chem; 2003 Nov; 278(47):46692-8. PubMed ID: 12963722
[TBL] [Abstract][Full Text] [Related]
37. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
Conese M; Blasi F
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
[TBL] [Abstract][Full Text] [Related]
38. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
Huang M; Mazar AP; Parry G; Higazi AA; Kuo A; Cines DB
Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):697-700. PubMed ID: 15930623
[TBL] [Abstract][Full Text] [Related]
39. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
[TBL] [Abstract][Full Text] [Related]
40. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
Rettenberger P; Wilhelm O; Oi H; Weidle UH; Goretzki L; Koppitz M; Lottspeich F; König B; Pessara U; Kramer MD
Biol Chem Hoppe Seyler; 1995 Oct; 376(10):587-94. PubMed ID: 8590627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]